Approximately half of patients diagnosed with rectal cancer are offered chemotherapy and radiotherapy treatment (CRT) before surgery. There is great variability in how each tumour responds to CRT. Approximately 30% of tumours completely respond and no cancer cells can be found in the cancer specimen removed at surgery. Other tumours do not respond at all or occasionally continue to grow during treatment.